🎉 M&A multiples are live!
Check it out!

Omeros Valuation Multiples

Discover revenue and EBITDA valuation multiples for Omeros and similar public comparables like Pharming, Julphar, and Benevolent AI.

Omeros Overview

About Omeros

Omeros Corp is a United States-based clinical-stage biopharmaceutical company engaged in discovering, developing, and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications targeting immunologic disorders including complement-mediated diseases, cancers, and addictive and compulsive disorders. The lead drug candidate in the pipeline of complement-targeted therapeutics is narsoplimab (OMS721), a proprietary, patented human monoclonal antibody targeting mannan-binding lectin-associated serine protease 2, the key activator of the lectin pathway of complement. Clinical development of narsoplimab is currently focused on hematopoietic stem cell transplant-associated thrombotic microangiopathy and immunoglobulin nephropathy.


Founded

1994

HQ

United States of America
Employees

202

Website

omeros.com

Financials

LTM Revenue $1.0M

LTM EBITDA n/a

EV

$523M

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Omeros Financials

Omeros has a last 12-month revenue of $1.0M and a last 12-month EBITDA of n/a.

In the most recent fiscal year, Omeros achieved revenue of n/a and an EBITDA of -$157M.

Omeros expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Omeros valuation multiples based on analyst estimates

Omeros P&L

FY 2023 FY 2024 FY 2025 LTM NTM
Revenue n/a n/a XXX XXX XXX
Gross Profit n/a n/a XXX XXX XXX
Gross Margin NaN% NaN% XXX XXX XXX
EBITDA -$143M -$157M XXX XXX XXX
EBITDA Margin -Infinity% -Infinity% XXX XXX XXX
Net Profit $47.4M -$118M XXX XXX XXX
Net Margin Infinity% -Infinity% XXX XXX XXX
Net Debt $304M $206M XXX XXX XXX

Financial data powered by Morningstar, Inc.

Omeros Stock Performance

As of April 15, 2025, Omeros's stock price is $7.

Omeros has current market cap of $406M, and EV of $523M.

See Omeros trading valuation data

Omeros Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$523M $406M XXX XXX XXX XXX $-2.63

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

Omeros Valuation Multiples

As of April 15, 2025, Omeros has market cap of $406M and EV of $523M.

Omeros's trades at 510.4x LTM EV/Revenue multiple, and n/a LTM EBITDA.

Analysts estimate Omeros's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for Omeros and 10K+ public comps

Omeros Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $523M XXX XXX XXX
EV/Revenue n/a XXX XXX XXX
EV/EBITDA -3.3x XXX XXX XXX
P/E -2.6x XXX XXX XXX
P/E/Growth n/a XXX XXX XXX
EV/FCF -3.5x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Omeros Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

Omeros Valuation Multiples

Omeros's NTM/LTM revenue growth is 3481%

Omeros's revenue per employee for the last fiscal year averaged n/a, while opex per employee averaged $0.8M for the same period.

Over next 12 months, Omeros's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate Omeros's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for Omeros and other 10K+ public comps

Omeros Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth n/a XXX XXX XXX XXX
EBITDA Margin n/a XXX XXX XXX XXX
EBITDA Growth 10% XXX XXX XXX XXX
Rule of 40 (SaaS-only) n/a XXX XXX XXX XXX
Revenue per Employee n/a XXX XXX XXX XXX
Opex per Employee $0.8M XXX XXX XXX XXX
S&M Expenses to Revenue n/a XXX XXX XXX XXX
G&A Expenses to Revenue n/a XXX XXX XXX XXX
R&D Expenses to Revenue n/a XXX XXX XXX XXX
Opex to Revenue n/a XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Omeros Public Comps

See public comps and valuation multiples for Drug Development & Therapeutics comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Julphar XXX XXX XXX XXX XXX XXX
Benevolent AI XXX XXX XXX XXX XXX XXX
Galapagos XXX XXX XXX XXX XXX XXX
Pharming XXX XXX XXX XXX XXX XXX
Vivoryon Therapeutics XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Omeros M&A and Investment Activity

Omeros acquired  XXX companies to date.

Last acquisition by Omeros was  XXXXXXXX, XXXXX XXXXX XXXXXX . Omeros acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Omeros

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About Omeros

When was Omeros founded? Omeros was founded in 1994.
Where is Omeros headquartered? Omeros is headquartered in United States of America.
How many employees does Omeros have? As of today, Omeros has 202 employees.
Who is the CEO of Omeros? Omeros's CEO is Dr. Gregory A. Demopulos,M.D..
Is Omeros publicy listed? Yes, Omeros is a public company listed on NAS.
What is the stock symbol of Omeros? Omeros trades under OMER ticker.
When did Omeros go public? Omeros went public in 2009.
Who are competitors of Omeros? Similar companies to Omeros include e.g. Julphar, Benevolent AI, Galapagos, Pharming.
What is the current market cap of Omeros? Omeros's current market cap is $406M
What is the current revenue of Omeros? Omeros's last 12-month revenue is $1.0M.
What is the current EV/Revenue multiple of Omeros? Current revenue multiple of Omeros is 510.4x.
Is Omeros profitable? Yes, Omeros is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.